Search - tctmd.com

Displaying 21 - 40 of 161

Sort: Relevancy | Date

News Conference News TCT 2017

Long-term Absorb BVS Data Continue to Disappoint

Michael O'Riordan

October 31, 2017

News Conference News TCT 2017

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Todd Neale

October 30, 2017

Presentation TCT 2017

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women

Presenter: Wayne B. Batchelor, George A. Mensah, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of African American/Latina Populations

Presenter: Wayne B. Batchelor, George A. Mensah

October 30, 2017

Presentation TCT 2017

National Evaluation System for Health Technology (NEST): Objectives, Accomplishments and Future Directions

Presenter: Mitchell W. Krucoff, John C Laschinger, Rachael L. Fleurence

October 30, 2017

Presentation TCT 2017

Enhancing Pre-Approval Studies to Better Evaluate Real-World Use: Lessons Learned and Future Opportunities

Presenter: Mitchell W. Krucoff, John C Laschinger

October 30, 2017

Presentation TCT 2017

Trial In the Pocket: Myheartcounts

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Alan C. Yeung

October 30, 2017

News Conference News TCT 2017

Live From Denver: TCT 2017, Day One

Shelley Wood

October 30, 2017

Presentation TCT 2017

Facebook and Twitter for Trial Recruitment: SCAD Case Example

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Jacqueline Saw

October 30, 2017

Presentation TCT 2017

Making the EHR Useful For Research: ADAPTABLE

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Adrian F Hernandez

October 30, 2017

Presentation TCT 2017

Keeping It Simple: Large Pragmatic Trials

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran

October 30, 2017

Presentation TCT 2017

The Inflammatory Hypothesis After CANTOS: CIRT

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation TCT 2017

Should Alleviating ISCHEMIA Be the Goal?

Presenter: Bernard J. Gersh, Robert A. Harrington, David J. Moliterno

October 30, 2017

Presentation TCT 2017

Primary Prevention in High Risk Patients II: THEMIS

Presenter: Bernard J. Gersh, Robert A. Harrington

October 30, 2017

Presentation TCT 2017

Primary Prevention In High Risk Patients I: REPRIEVE

Presenter: Bernard J. Gersh, Robert A. Harrington, Pamela S. Douglas

October 30, 2017

News Conference News TCT 2017

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Todd Neale

October 30, 2017

Presentation TCT 2017

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Presenter: David H. Adams, Ted Feldman, Gilles Dreyfus

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Presenter: David H. Adams, Ted Feldman, Allan Schwartz

October 30, 2017

Presentation TCT 2017

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Presenter: David H. Adams, Ted Feldman, Vinod H. Thourani

October 30, 2017

Advertisement

Long-term Absorb BVS Data Continue to Disappoint

DARE Supports Drug-Coated Balloon as Alternative to DES for Any In-Stent Restenosis

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of Women

Diversity in Clinical Trials (Lessons Learned, Future Directions): Inclusion of African American/Latina Populations

National Evaluation System for Health Technology (NEST): Objectives, Accomplishments and Future Directions

Enhancing Pre-Approval Studies to Better Evaluate Real-World Use: Lessons Learned and Future Opportunities

Trial In the Pocket: Myheartcounts

Live From Denver: TCT 2017, Day One

Facebook and Twitter for Trial Recruitment: SCAD Case Example

Making the EHR Useful For Research: ADAPTABLE

Keeping It Simple: Large Pragmatic Trials

The Inflammatory Hypothesis After CANTOS: CIRT

The LDL Hypothesis Post FOURIER: Heading Home From ODYSSEY

Should Alleviating ISCHEMIA Be the Goal?

Primary Prevention in High Risk Patients II: THEMIS

Primary Prevention In High Risk Patients I: REPRIEVE

Help for Clinicians Whose Patients Need to Switch P2Y12 Inhibitors

Predicting The Future: Will the Ongoing COAPT Trial Change How We Treat Patients With Secondary MR in Heart Failure?

Predicting the Future: Will the Ongoing TAVR UNLOAD and Early TAVR Trials Change the Threshold for TAVR in Moderate and Asymptomatic Aortic Stenosis?

Predicting the Future: Will the Ongoing GALILEO and ENVISAGE AF Trials Change How We Anticoagulate Patients After TAVR?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content